Photocure Stock Fundamentals
| PHO Stock | NOK 50.50 2.10 4.34% |
Photocure fundamentals help investors to digest information that contributes to Photocure's financial success or failures. It also enables traders to predict the movement of Photocure Stock. The fundamental analysis module provides a way to measure Photocure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Photocure stock.
Photocure |
Photocure Company Return On Equity Analysis
Photocure's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Photocure Return On Equity | -0.16 |
Most of Photocure's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Photocure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Photocure has a Return On Equity of -0.1567. This is 99.35% lower than that of the Pharmaceuticals sector and 107.29% lower than that of the Health Care industry. The return on equity for all Norway stocks is 49.45% lower than that of the firm.
Photocure Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Photocure's current stock value. Our valuation model uses many indicators to compare Photocure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Photocure competition to find correlations between indicators driving Photocure's intrinsic value. More Info.Photocure is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Photocure's earnings, one of the primary drivers of an investment's value.Photocure Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Photocure's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Photocure could also be used in its relative valuation, which is a method of valuing Photocure by comparing valuation metrics of similar companies.Photocure is currently under evaluation in return on equity category among its peers.
Photocure Fundamentals
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0309 | |||
| Profit Margin | (0.20) % | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | 2.77 B | |||
| Shares Outstanding | 27.11 M | |||
| Shares Owned By Insiders | 2.98 % | |||
| Shares Owned By Institutions | 48.69 % | |||
| Price To Earning | 91.78 X | |||
| Price To Book | 6.33 X | |||
| Price To Sales | 7.76 X | |||
| Revenue | 360.54 M | |||
| Gross Profit | 336.49 M | |||
| EBITDA | 16.3 M | |||
| Net Income | (30.9 M) | |||
| Cash And Equivalents | 319.04 M | |||
| Cash Per Share | 4.20 X | |||
| Total Debt | 12.5 M | |||
| Debt To Equity | 5.50 % | |||
| Current Ratio | 3.04 X | |||
| Book Value Per Share | 17.69 X | |||
| Cash Flow From Operations | 23.89 M | |||
| Earnings Per Share | (2.53) X | |||
| Target Price | 141.67 | |||
| Number Of Employees | 97 | |||
| Beta | 0.79 | |||
| Market Capitalization | 3.07 B | |||
| Total Asset | 789.65 M | |||
| Retained Earnings | 153 M | |||
| Working Capital | 163 M | |||
| Current Asset | 195 M | |||
| Current Liabilities | 32 M | |||
| Net Asset | 789.65 M |
About Photocure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Photocure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Photocure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Photocure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment in Nordic countries and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. PHOTOCURE ASA operates under Drug Manufacturers - Major classification in Norway and is traded on Oslo Stock Exchange. It employs 71 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Photocure Stock
Photocure financial ratios help investors to determine whether Photocure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Photocure with respect to the benefits of owning Photocure security.